EUVIMEDEUVIMED entdecken
Open Access

In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity

Jonathan H Sussman iD, Hector W Cure, Salina Yuan, Kenji Ito, Irfan A Asangani, Benjamin A Garcia, Ben Z Stanger iD, Takeshi Katsuda iD

Genes & Development · 01.05.2025 · 39 (9-10) · 603-616

DOI: 10.1101/gad.352420.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, online erschienen am 01.04.2025. Verfasst von Jonathan H Sussman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Cellular Reprogramming, Liver, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NICHD NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following prolonged liver injury, a small fraction of hepatocytes undergoes reprogramming to become cholangiocytes or biliary epithelial cells (BECs). This physiological process involves chromatin and transcriptional remodeling, but the epigenetic mediators are largely unknown. Here, we exploited a lineage-traced model of liver injury to investigate the role of histone post-translational modification in biliary reprogramming. Using mass spectrometry, we defined the repertoire of histone marks that are globally altered in quantity during reprogramming. Next, applying an in vivo CRISPR screening approach, we identified seven histone-modifying enzymes that alter the efficiency of hepatobiliary reprogramming. Among these, the histone methyltransferase and demethylase Nsd1 and Kdm2a were found to have reciprocal effects on H3K36 methylation that regulated the early and late stages of reprogramming, respectively. Although loss of Nsd1 and Kdm2a affected reprogramming efficiency, cells ultimately acquired the same transcriptomic states. These findings reveal that multiple chromatin regulators exert dynamic and complementary activities to achieve robust cell fate switching, serving as a model for the cell identity changes that occur in various forms of physiological metaplasia or reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticCellular ReprogrammingLiverClustered Regularly Interspaced Short Palindromic RepeatsAnimalsMiceHistonesHepatocytesHistone-Lysine N-MethyltransferaseEpithelial CellsJumonji Domain-Containing Histone DemethylasesMethylation

Stichwörter der Autor:innen

CRISPR screeningcellular plasticityepigeneticshepatocytehistone modifiermetaplasiareprogramming

Substanzen

HistonesHistone-Lysine N-MethyltransferaseJumonji Domain-Containing Histone Demethylases

Autor:innen und Institutionen

  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Penn Epigenetics Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; tkatsuda412@gmail.com bstanger@upenn.edu.

ORCID-Profile: Jonathan H Sussman, Ben Z Stanger, Takeshi Katsuda

Förderung

  • NCI NIH HHS
  • NICHD NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • Fred and Suzanne Biesecker Pediatric Liver Center
  • Abramson Family Cancer Research Institute
  • International Medical Research Foundation
  • Daiichi Sankyo Foundation of Life Science

Zitieren

APA

Sussman, J. H., Cure, H. W., Yuan, S., Ito, K., Asangani, I. A., Garcia, B. A., Stanger, B. Z., & Katsuda, T. (2025). In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. Genes & Development, 39(9-10), 603-616. https://doi.org/10.1101/gad.352420.124

Vancouver

Sussman JH, Cure HW, Yuan S, Ito K, Asangani IA, Garcia BA, et al. In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. Genes & Development. 2025;39(9-10):603-616. doi:10.1101/gad.352420.124

BibTeX
@article{Sussman2025,
  author = {Sussman, Jonathan H and Cure, Hector W and Yuan, Salina and Ito, Kenji and Asangani, Irfan A and Garcia, Benjamin A and Stanger, Ben Z and Katsuda, Takeshi},
  title = {In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity},
  journal = {Genes & Development},
  year = {2025},
  volume = {39},
  number = {9-10},
  pages = {603--616},
  doi = {10.1101/gad.352420.124}
}
Kostenlos starten →